Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP7 | P09237 | 3/20 | 0.69 |
| ▸ | MMP12 | P39900 | 3/20 | 0.69 |
| ▸ | MMP3 | P08254 | 2/20 | 0.69 |
| ▸ | MMP10 | P09238 | 2/20 | 0.69 |
| ▸ | MMP8 | P22894 | 2/20 | 0.69 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.51 |
| ▸ | PTAFR | P25105 | 1/20 | 0.50 |
| ▸ | BRD4 | O60885 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4937089 | 0.95 | MMP7 (0.69) | MMP7MMP12MMP3MMP10MMP8 | |
| SCHEMBL4937077 | 0.95 | MMP7 (0.69) | MMP7MMP12MMP3MMP10MMP8 | |
| SCHEMBL3724630 | 0.88 | MMP7 (0.57) | MMP7MMP12MMP3MMP10MMP8 | |
| SCHEMBL3728687 | 0.85 | HRH3 (0.64) | MMP7MMP12MMP3MMP10MMP8 | |
| SCHEMBL4937732 | 0.83 | PTAFR (0.71) | MMP7MMP12MMP3MMP10MMP8 | |
| SCHEMBL3725969 | 0.83 | HDAC1 (0.55) | MMP7MMP12MMP3MMP10MMP8 | |
| SCHEMBL3809256 | 0.81 | HRH3 (0.60) | MMP7MMP12MMP3MMP10MMP8 | |
| SCHEMBL7756336 | 0.81 | HDAC4 (0.51) | MMP7MMP12MMP3MMP10MMP8 | |
| SCHEMBL3666262 | 0.80 | HRH3 (0.69) | MMP7MMP12MMP3MMP10MMP8 | |
| SCHEMBL3666267 | 0.80 | HRH3 (0.69) | MMP7MMP12MMP3MMP10MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2155719-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | Wyeth LLC (US) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008147945-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | WYETH (US) | 2008-12-04 | — | — | WO | disclosed |
| US-20080293771-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | WYETH (US) | 2008-11-27 | — | — | US | disclosed |
| US-20080293771-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | WYETH (US) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293771-A1 | AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS | HRH4, HRH3, HRH2 | MMP7 3853/4885MMP12 2971/4885MMP3 3511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.